Across TCGA pan-cancer cohorts, CFAP251 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated CFAP251 data layer compared with 24 for mass-spec protein and 6 for mutation status.
The strongest signal is observed in lung adenocarcinoma (LUAD), where higher CFAP251 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated CFAP251 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.
LUAD and UCEC are the cancer types where CFAP251 mass-spec protein most reproducibly stratifies survival.